Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to understand what the trial involves and what is required of them.
- People aged 18 or older.
- People who have had lung cancer confirmed through a tissue or cell sample test.
- People who are reasonably active and able to care for themselves (a standard medical scoring system is used to assess this — confirm with trial site).
- People whose doctors expect them to live for at least 12 weeks.
- People whose blood counts and organ function are within acceptable ranges (confirm with trial site).
- People who have at least one tumour that can be measured using standard imaging methods.
Who may not be able to join:
- People who received radiation therapy within the 14 days before starting the trial, or who have not yet recovered from side effects of radiation — though some specific types of radiotherapy may be permitted from 7 days before starting (confirm with trial site).
- People who are currently taking, or cannot stop taking, certain medications or herbal supplements that affect how the body processes drugs (known as CYP1A2 or CYP3A inhibitors or inducers) within 1–2 weeks before starting the trial (confirm with trial site).
- People who have cancer that has spread to compress the spinal cord, or cancer that has spread to the membranes surrounding the brain and spinal cord.
- People who have been diagnosed with another cancer within the past 2 years.
- People who still have side effects from previous cancer treatments (such as chemotherapy or radiotherapy) that are more than mild in severity, except for hair loss.
- People who have had a stroke or bleeding in the brain within the 6 months before starting the trial.
- People with severe or poorly managed conditions such as uncontrolled high blood pressure or active bleeding.
- People with an ongoing or active infection, including hepatitis B, hepatitis C, HIV, or COVID-19.
- People with certain heart-related conditions or abnormalities (confirm with trial site for details).
- People with a history of certain types of lung inflammation or scarring, including conditions caused by previous drug treatments, radiotherapy, or immunotherapy.
- People who have ongoing nausea or vomiting that cannot be controlled, a chronic gut condition, difficulty swallowing tablets or capsules, or poor absorption of medications due to previous bowel surgery.
- People who received a live vaccine within 2 weeks before starting the trial.
- People who are pregnant or currently breastfeeding.
- People who are known to be allergic to the trial drug or any of its ingredients.
- People whom the trial doctors consider unsuitable for participation for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yongchang Zhang, MD, zhangyongchang@csu.edu.cn
Phone: +8613873123436
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.